Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07055516 · ClinicalTrials.gov registry record · Phase 2

Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus

A Phase 2 study of Obesity and Type 2 Diabetes, sponsored by NodThera Limited.

Active
Registry status
Phase 2
Development phase
162
Enrollment target
11
Study locations

NCT07055516 is a Phase 2 study of Obesity and Type 2 Diabetes that is active but no longer recruiting, run by NodThera Limited. The registered enrollment target is 162 participants, above the 56-participant average among 5 other Obesity and Type 2 Diabetes trials with a reported enrollment target (189% higher). The trial reports 11 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07055516, a Phase 2 study of Obesity and Type 2 Diabetes, is active but no longer recruiting, sponsored by NodThera Limited.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
162 participants
Enrollment target
11
Study locations

Study Summary

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.

Conditions Studied

Obesity and Type 2 Diabetes

Interventions

  • DRUG Placebo
  • DRUG NT-0796

Study Locations (11)

Florida

  • Investigative site - Cooper City
  • Investigative Site - Hialeah
  • Investigative Site - Jacksonville
  • Investigative Site - Miami
  • Investigative Site - Port Orange

Arizona

  • Investigative site - Mesa

California

  • Investigative site - Los Angeles

Louisiana

  • Investigative Sites - Marrero

Ohio

  • Investigative Site - Columbus

Texas

  • Investigative Site - Dallas

Virginia

  • Investigative Site - Manassas

Trial Details

FieldValue
Enrollment Target 162 participants
Start Date 2025-05-08
Est. Completion 2026-03-31
Phase Phase 2

Sponsor

NodThera Limited

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07055516

The ClinicalTrials.gov registry entry for NCT07055516 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 56-participant average among 5 other Obesity and Type 2 Diabetes trials with a reported enrollment target (189% higher). The listed sponsor is NodThera Limited, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity and Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07055516 reports 11 study locations spanning 7 distinct geographic areas - top geographies include Florida, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT07055516 about?

NCT07055516 is a clinical study titled "Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus". A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participants With/Without Type 2 Diabetes over a 6 months treatment period.

What is the current status of trial NCT07055516?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 162 participants. The study started on 2025-05-08. Estimated completion is 2026-03-31.

What conditions does trial NCT07055516 study?

This clinical trial studies the following conditions: Obesity and Type 2 Diabetes.

What interventions are being tested in trial NCT07055516?

The interventions under investigation include: Placebo (DRUG), NT-0796 (DRUG).

Who is sponsoring clinical trial NCT07055516?

This trial is sponsored by NodThera Limited, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07055516 being conducted?

This trial has 11 study locations across Arizona, California, Florida, Louisiana, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity and Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Obesity and Type 2 Diabetes

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.